IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Mabvax Therapeutics Hldgs in

Q2 2022 vs Q3 2022

Comparing institutional holders between quarters

Quarters

Q3 2022Q2 2022Q4 2021Q3 2021Q2 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Eagle Bay Advisors LLC
UNCHANGED
Shares23 from 23
Change0 (0%)
Value$0 ($0)
Filed 2022-11-23
Status
Eagle Bay Advisors LLC
UNCHANGED232300%$0$0$02022-11-23
Showing 1 of 1 institutions